


Boston Collaborative Drug Surveillance Program (BCDSP) Revenue
Research Services • Lexington, Massachusetts, United States • 1-10 Employees
Boston Collaborative Drug Surveillance Program (BCDSP) revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Key Contacts at Boston Collaborative Drug Surveillance Program (BCDSP)
Susan Jick
Director And Epidemiologist
Michael Horton
Director Of Administration
Company overview
| Headquarters | 11 Muzzey St, Lexington, Massachusetts 02421, US |
| Phone number | +17818626660 |
| Website | |
| SIC | 283 |
| Keywords | Epidemiology, Pharmacoepidemiology, Drug Safety, Observational Research, Clinical Practice Research Datalink, Post Authorizaton Safety Studies |
| Founded | 1966 |
| Employees | 1-10 |
| Socials |
Boston Collaborative Drug Surveillance Program (BCDSP) Email Formats
Boston Collaborative Drug Surveillance Program (BCDSP) uses 2 email formats. The most common is {first name} (e.g., john@bcdsp.org), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@bcdsp.org | 66.7% |
{first initial} | j@bcdsp.org | 33.3% |
About Boston Collaborative Drug Surveillance Program (BCDSP)
Boston Collaborative Drug Surveillance Program (BCDSP) is an independent, nonprofit research group with over 40 years of expertise in the design and conduct of pharmacoepidemiology and disease epidemiology research using existing data sources. We primarily use electronic health data collected in the United Kingdom and United States, combined with rigorous epidemiological and statistical methods, to produce real world evidence to support clinical, regulatory, and pharma decision making. The BCDSP makes significant and valuable contributions in the generation of real-world evidence in support of drug development programs, new drug applications, and post-marketing safety surveillance, as well as to inform public health and clinical decisions. We have extensive experience in the design and conduct of disease epidemiology studies to identify risk factors, describe disease progression and comorbidities, and in post authorization safety studies (PASS) to assess safety of newly marketed treatments. Studies conducted by our group cover a broad range of drugs and diseases. The BCDSP, over its 35-year association, has attained unparalleled knowledge of and made major contributions to the development and validation of the United Kingdom Clinical Practice Research Datalink (CPRD) and linked resources and also has broad experience with US claims and electronic health record databases. The BCDSP also offers professional education in drug epidemiology and welcomes collaborators from government, industry, and academia.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Boston Collaborative Drug Surveillance Program (BCDSP) has 4 employees across 2 departments.
Departments
Number of employees
Funding Data
Boston Collaborative Drug Surveillance Program (BCDSP) has never raised funding before.
Boston Collaborative Drug Surveillance Program (BCDSP) Tech Stack
Discover the technologies and tools that power Boston Collaborative Drug Surveillance Program (BCDSP)'s digital infrastructure, from frameworks to analytics platforms.
Font scripts
Miscellaneous
Reverse proxies
Programming languages
Hosting
WordPress themes
Blogs
Databases
Miscellaneous
Performance
Frequently asked questions
4.8
40,000 users



